Literature DB >> 34755536

Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels.

Stephen J Keely1, Andreacarola Urso2,3, Alexandr V Ilyaskin4, Christoph Korbmacher4, Nigel W Bunnett5,6, Daniel P Poole7,8, Simona E Carbone7,8.   

Abstract

Bile acids (BAs) are known to be important regulators of intestinal motility and epithelial fluid and electrolyte transport. Over the past two decades, significant advances in identifying and characterizing the receptors, transporters, and ion channels targeted by BAs have led to exciting new insights into the molecular mechanisms involved in these processes. Our appreciation of BAs, their receptors, and BA-modulated ion channels as potential targets for the development of new approaches to treat intestinal motility and transport disorders is increasing. In the current review, we aim to summarize recent advances in our knowledge of the different BA receptors and BA-modulated ion channels present in the gastrointestinal system. We discuss how they regulate motility and epithelial transport, their roles in pathogenesis, and their therapeutic potential in a range of gastrointestinal diseases.

Entities:  

Keywords:  FXR; TGR5; bile acid; motility; secretion

Mesh:

Substances:

Year:  2021        PMID: 34755536      PMCID: PMC8782647          DOI: 10.1152/ajpgi.00125.2021

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  233 in total

Review 1.  Activation of the epithelial sodium channel (ENaC) by serine proteases.

Authors:  Bernard C Rossier; M Jackson Stutts
Journal:  Annu Rev Physiol       Date:  2009       Impact factor: 19.318

Review 2.  Beyond somatosensation: Mrgprs in mucosal tissues.

Authors:  Juan M Inclan-Rico; Brian S Kim; Ishmail Abdus-Saboor
Journal:  Neurosci Lett       Date:  2021-02-11       Impact factor: 3.046

3.  Effects on small-intestinal function and structure induced by feeding a deconjugated bile salt.

Authors:  M Gracey; J Papadimitriou; V Burke; J Thomas; G Bower
Journal:  Gut       Date:  1973-07       Impact factor: 23.059

4.  Randomised clinical trial: significant biochemical and colonic transit effects of the farnesoid X receptor agonist tropifexor in patients with primary bile acid diarrhoea.

Authors:  Michael Camilleri; Sara Linker Nord; Duane Burton; Ibironke Oduyebo; Yiming Zhang; Jin Chen; Koeun Im; Prafulla Bhad; Michael K Badman; David S Sanders; Julian R F Walters
Journal:  Aliment Pharmacol Ther       Date:  2020-07-23       Impact factor: 8.171

5.  Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.

Authors:  Atsushi Nakajima; Mitsunori Seki; Shinya Taniguchi; Akira Ohta; Per-Göran Gillberg; Jan P Mattsson; Michael Camilleri
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-05-25

6.  An analysis of cosecretion and coexpression of gut hormones from male rat proximal and distal small intestine.

Authors:  Berit Svendsen; Jens Pedersen; Nicolai Jacob Wewer Albrechtsen; Bolette Hartmann; Signe Toräng; Jens F Rehfeld; Steen Seier Poulsen; Jens Juul Holst
Journal:  Endocrinology       Date:  2014-12-23       Impact factor: 4.736

7.  Luminal peptide YY-releasing factors in the isolated vascularly perfused rat colon.

Authors:  P Plaisancié; V Dumoulin; J A Chayvialle; J C Cuber
Journal:  J Endocrinol       Date:  1996-12       Impact factor: 4.286

8.  Basolateral Ca2+-dependent K+-channels play a key role in Cl- secretion induced by taurodeoxycholate from colon mucosa.

Authors:  Antonio Moschetta; Piero Portincasa; Lucantonio Debellis; Michele Petruzzelli; Roberta Montelli; Giuseppe Calamita; Pontus Gustavsson; Giuseppe Palasciano
Journal:  Biol Cell       Date:  2003 Mar-Apr       Impact factor: 4.458

9.  Bile acid malabsorption deactivates pregnane X receptor in patients with Crohn's disease.

Authors:  Junichi Iwamoto; Yoshifumi Saito; Akira Honda; Teruo Miyazaki; Tadashi Ikegami; Yasushi Matsuzaki
Journal:  Inflamm Bowel Dis       Date:  2013-05       Impact factor: 5.325

10.  A randomized placebo-controlled phase IIb trial of a3309, a bile acid transporter inhibitor, for chronic idiopathic constipation.

Authors:  William D Chey; Michael Camilleri; Lin Chang; Leif Rikner; Hans Graffner
Journal:  Am J Gastroenterol       Date:  2011-05-24       Impact factor: 10.864

View more
  4 in total

Review 1.  Bile acid detergency: permeability, inflammation, and effects of sulfation.

Authors:  Michael Camilleri
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2022-03-08       Impact factor: 4.052

Review 2.  Gut microbiota: a new avenue to reveal pathological mechanisms of constipation.

Authors:  Lei Yang; Yu Wang; Yun Zhang; Wenwen Li; Shu Jiang; Dawei Qian; Jinao Duan
Journal:  Appl Microbiol Biotechnol       Date:  2022-10-03       Impact factor: 5.560

3.  Gastrointestinal neoplasia: carcinogenic interaction between bile acids and Helicobacter pylori in the stomach.

Authors:  Madeline Alizadeh; Jean-Pierre Raufman
Journal:  J Clin Invest       Date:  2022-05-16       Impact factor: 19.456

4.  Elucidation of the Reinforcing Spleen Effect of Jujube Fruits Based on Metabolomics and Intestinal Flora Analysis.

Authors:  Yan-Ling Yi; Yao Li; Sheng Guo; Hui Yan; Xin-Fei Ma; Wei-Wei Tao; Er-Xin Shang; Yang Niu; Da-Wei Qian; Jin-Ao Duan
Journal:  Front Cell Infect Microbiol       Date:  2022-03-24       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.